More about
Corticotropin Injection
News
March 01, 2024
1 min read
Save
FDA approves Acthar Gel SelfJect injector in autoimmune, inflammatory conditions
The FDA has approved a supplemental new drug application for an Acthar Gel injector for the treatment of several chronic and acute inflammatory and autoimmune conditions, according to the manufacturer.